NSAID: an update on their analgesic effects

Clinical and Experimental Pharmacology & Physiology
J S Walker

Abstract

1. The non-steroidal anti-inflammatory drugs (NSAID) are a group of drugs that possess both analgesic and anti-inflammatory properties. They are used to treat a variety of painful and inflammatory disorders such as postoperative pain, dental surgery, headache, acute and chronic musculoskeletal pain. 2. There is now substantial evidence that NSAID produce analgesia by inhibiting prostaglandin (PG) synthesis both in the peripheral and central nervous system. However, other mechanisms of action should also be considered. There is a multiplicity of mediators capable of producing pain, and NSAID may act both on the peripheral and central nervous system to modulate such mediators. There is a growing body of evidence suggesting that NSAID can exert an effect on specific G-protein dependent functions. 3. There is significant intra- and interpatient variability in the response to NSAID. Development of tolerance after multiple doses may provide an explanation for the unsatisfactory response to NSAID in some patients. 4. It has been suggested that the rate of decline of drug effect is characteristic of analgesia itself and indicates that an endogenous substance mediates the analgesic effect; possible candidates include serotonin. 5. NSAID...Continue Reading

References

Jan 1, 1979·Chemical & Pharmaceutical Bulletin·J ShibasakiT Koizumi
Feb 1, 1991·Trends in Neurosciences·J Garthwaite
Jul 1, 1991·British Medical Bulletin·C J Woolf
Oct 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·A CataniaJ M Lipton
Dec 1, 1990·Stroke; a Journal of Cerebral Circulation·S DohiR J Traystman
Jan 1, 1989·Arthritis and Rheumatism·S B Abramson, G Weissmann
Oct 1, 1980·British Journal of Clinical Pharmacology·S H Ferreira
Aug 1, 1983·Seminars in Arthritis and Rheumatism·G Weissmann
Nov 1, 1982·British Journal of Clinical Pharmacology·D L ScottM J Kendall
Sep 1, 1980·British Journal of Clinical Pharmacology·M A MartinJ W Ward
Oct 1, 1980·British Journal of Clinical Pharmacology·G Levy
Oct 1, 1980·British Journal of Clinical Pharmacology·S L WallensteinR W Houde
Jan 14, 1994·European Journal of Pharmacology·C R Tonussi, S H Ferreira
Aug 12, 1994·Science·E Kopp, S Ghosh
Dec 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·J A MitchellJ R Vane

❮ Previous
Next ❯

Citations

May 28, 1998·Journal of Pain and Symptom Management·R B Sheather-Reid, M Cohen
Nov 9, 2000·The European Journal of Neuroscience·V Tortorici, H Vanegas
Mar 28, 2009·The International Journal of Neuroscience·Ibrahim Yilmaz, Ahmet Ulugol
Dec 29, 2009·European Journal of Pharmacology·Nana TsiklauriMerab G Tsagareli
Oct 22, 2004·European Journal of Pharmacology·Robert B RaffaSteven N Sterious
Nov 8, 2003·Rheumatic Diseases Clinics of North America·Robert B Raffa
Mar 5, 2008·European Journal of Pharmacology·Philippe GirardJean-Marie Gillardin
Jan 18, 2008·Brain Research·Brian E CairnsPeter Svensson
Jun 26, 2003·The European Journal of Neuroscience·Hawon ChoUhtaek Oh
Apr 29, 2010·Pharmaceuticals·Horacio VanegasVictor Tortorici
Aug 26, 2004·Pain·Alejandro J Pernia-AndradeHoracio Vanegas
Jan 16, 1997·Nature·W S LealY Ueda
Jul 2, 2005·Expert Opinion on Emerging Drugs·J B CalixtoA R Santos
Feb 2, 2013·The Clinical Journal of Pain·Jahan PorhomayonNader D Nader
Aug 29, 2000·Phytotherapy Research : PTR·J B CalixtoR A Yunes
Sep 15, 2000·Journal of Neurochemistry·W A LinkJ R Naranjo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.